JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 90: 395-404, 2003. First published February 26, 2003; doi:10.1152/jn.01058.2002
0022-3077/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/1/395    most recent
01058.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davila, N. G.
Right arrow Articles by Trombley, P. Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davila, N. G.
Right arrow Articles by Trombley, P. Q.

Dopamine Modulates Synaptic Transmission Between Rat Olfactory Bulb Neurons in Culture

Nestor G. Davila, Laura J. Blakemore and Paul Q. Trombley

Department of Biological Science, Program in Neuroscience, Florida State University, Tallahassee, Florida 32306-4340

Submitted 22 November 2002; accepted in final form 23 February 2003


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
The glomerular layer of the olfactory bulb (OB) contains synaptic connections between olfactory sensory neurons and OB neurons as well as connections among OB neurons. A subpopulation of external tufted cells and periglomerular cells (juxtaglomerular neurons) expresses dopamine, and recent reports suggest that dopamine can inhibit olfactory sensory neuron activation of OB neurons. In this study, whole cell electrophysiological and primary culture techniques were employed to characterize the neuromodulatory properties of dopamine on glutamatergic transmission between rat OB mitral/tufted (M/T) cells and interneurons. Immunocytochemical analysis confirmed the expression of tyrosine hydroxylase, the rate-limiting enzyme for dopamine synthesis, in a subpopulation of cultured neurons. D2 receptor immunoreactivity was also observed in cultured M/T cells. Dopamine reduced spontaneous excitatory synaptic events recorded in interneurons. Although the D1 receptor agonist SKF38393 and the D2 receptor agonist bromocriptine mesylate mimicked this effect, evoked excitatory postsynaptic potentials (EPSPs) recorded from monosynaptically coupled neuron pairs were attenuated by dopamine and bromocriptine but not by SKF38393. Neither glutamate-evoked currents nor the membrane resistance of the postsynaptic interneuron were affected by dopamine. However, evoked calcium channel currents in the presynaptic M/T cell were diminished during the application of either dopamine or bromocriptine, but not SKF38393. Dopamine suppressed calcium channel currents even after nifedipine blockade of L-type channels, suggesting that inhibition of the dihydropyridine-resistant high-voltage activated calcium channels implicated in transmitter release may mediate dopamine's effects on spontaneous and evoked synaptic transmission. Together, these data suggest that dopamine inhibits excitatory neurotransmission between M/T cells and interneurons via a presynaptic mechanism.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Although many aspects of dopamine in the olfactory bulb (OB) have been characterized over the past few decades, much remains to be understood about the role(s) of dopamine in olfactory information processing. It has been known for some time that subpopulations of both periglomerular neurons in the glomerular layer and tufted cells in the superficial external plexiform layers of the OB express tyrosine hydroxylase (TH), the rate-limiting enzyme for the synthesis of dopamine (Halasz et al. 1981Go). Other investigators have characterized the laminar and cellular expression of both D1 and D2 dopamine receptor subtypes in the OB (Coronas et al. 1997Go; Koster et al. 1999Go; Levey et al. 1993Go).

Olfactory experience has a significant effect on the expression of TH, OB dopamine content, and D2 receptors. After unilateral naris occlusion, TH and dopamine content decreases sharply (Baker et al. 1983Go) and D2 receptor expression dramatically increases (Guthrie et al. 1991Go). Behavioral experiments have shown that D1 receptor activation improved odor detection performance (Doty et al. 1998Go). Conversely, D2 receptor activation diminished odor detection performance in another series of experiments (Doty and Risser 1989Go).

Using electrophysiological techniques, other investigators have shown that dopamine reduces evoked potentials in mitral cells from the turtle OB (Nowycky et al. 1983Go) and the rat OB (Ennis et al. 2001Go). Furthermore, the reduction in endogenous dopamine caused by naris closure augments both the number of mitral cells that respond to an individual odorant and the number of odorants to which an individual mitral cell will respond upon odor presentation to the reopened naris (Wilson and Sullivan 1995Go). Recent electrophysiological studies have shed some light on the synaptic mechanisms underlying these effects. D2 receptor activation on the presynaptic terminal of olfactory receptor neurons (ORNs) decreases the probability of glutamate release, and hence, excitability of mitral/tufted (M/T) cells is diminished (Berkowicz and Trombley 2000Go; Ennis et al. 2001Go; Hsia et al. 1999Go). Also, activation of different dopamine receptor subtypes on M/T cells (D2) and interneurons (D1) mediates differential yet complementary transduction cascades with the overall effect of increasing GABAergic inhibition of M/T cells (Brunig et al. 1999Go).

In this study, we combined patch-clamp electrophysiological recording with primary culture techniques to further identify the synaptic effects of dopamine. Our results suggest that dopamine may contribute to odor information processing through presynaptic inhibition of excitatory synaptic transmission between M/T cells and interneurons.


    METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Tissue culture

The procedure for preparing primary cultures of OB neurons is described in detail elsewhere (Trombley and Blakemore 1999Go). Briefly, P1–P5 Sprague-Dawley rat pups were decapitated in accordance with the institutional guidelines of The Care and Use of Laboratory Animals approved by the National Institutes of Health and The Florida State University's Animal Care and Use Committee. OBs were removed, cut into 1-mm cubes, and enzymatically treated in a calcium-buffered papain solution for 1 h at 37°C. The OBs were triturated with a fire-polished pipette until a single-cell suspension was achieved. The cells (250,000 cells/dish) were plated in 35-mm culture dishes on a confluent monolayer of previously prepared OB astrocytes. The neuronal media was comprised of 95% minimal essential medium (MEM, Gibco), 5% horse serum (Gibco), 6 g/l glucose, and a nutrient supplement (Serum Extender, Collaborative Research). Astrocyte layers were obtained by plating a suspension of OB cells in a 75-cm2 flask containing 90% MEM, 10% fetal calf serum, and 6 g/l glucose. Once confluent, the cells were resuspended enzymatically with 0.125% trypsin and plated onto 35-mm dishes coated with poly-L-lysine (30,000–70,000 MW, 10 µg/ml, Sigma). Addition of 105 M cytosine-{beta}-D-arabinofuranoside (Sigma) to the media 1 day after plating the neurons prevented the overgrowth of astrocytes.

Neuronal Identity

Presumptive M/T cells and interneurons were identified based on the morphological, physiological, and immunohistochemical criteria established by Trombley and Westbrook (1990Go). Briefly, the cultures contained morphologically distinct populations of neurons: a small number of large-diameter pyramidal-shaped neurons (20–40 µm soma) and a much larger population of small-diameter bipolar neurons (5–10 µm soma). These characteristics correlate with M/T and granule/periglomerular cells, respectively. Electrophysiological analyses of these two morphologically distinct populations further support the notion that they reflect M/T cells and interneurons. Intracellular stimulation of neurons with morphology reflecting M/T cells in vivo invariably evoked glutamate-mediated EPSPs in monosynaptically coupled interneurons. In contrast, intracellular stimulation of the small bipolar neurons evoked GABA-mediated IPSPs, consistent with their identity as interneurons. We have previously shown that these morphologically and physiologically distinct populations can also be identified by immunohistochemical markers. The large pyramidal neurons, the presumptive M/T cells, were N-acetylaspartylglutamate immunoreactive; in contrast, the small bipolar neurons, presumptive granule/periglomerular neurons, were glutamic acid decarboxylase immunoreactive (Trombley and Westbrook 1990Go).

Electrophysiology

Electrophysiological recordings were obtained at room temperature from OB neurons after 6–14 days in culture. The acquisition software (AxoData and AxoGraph, Axon Instruments) was run on a Macintosh G3 computer and used to control an AxoClamp 2B amplifier (Axon Instruments).

The 35-mm culture dishes functioned as the recording chambers and were perfused at 0.5–2.0 ml/min with a bath solution consisting of (in mM) 162.5 NaCl, 2.5 KCl, 2 CaCl2, 10 HEPES, 10 glucose, 0 MgCl2, and 1 µM glycine (pH 7.3, osmolarity 325 mOsm). Patch electrodes were pulled from borosilicate glass to a final tip resistance of 4–6 MOhm and filled with a solution containing (in mM) 145 KMeSO4 or CsCl, 1 MgCl2, 10 HEPES, 5 Mg-ATP, 0.5 Mg-GTP, and 1.1 EGTA (pH 7.2, osmolarity 310 mOsm).

Drugs were diluted in bath solution and applied via a gravity-fed flow-pipe perfusion system, comprised of a row of 600 µm OD, square glass barrels. An electronic manipulator (Warner Instruments) controlled the position of the flow pipes, and pinch clamps regulated drug delivery. The solution delivery system produced complete drug exchange within 100 ms. In the text and figures, "control" data represent cells perfused with bath solution. The drugs used in these experiments were dopamine, glutamate, tetrodotoxin (TTX), SKF38393 (all from Sigma), and bromocriptine mesylate (from Tocris).

Spontaneous synaptic activity was recorded from interneurons in current-clamp mode. Quantitative analyses of the effects of dopamine and dopamine receptor agonists were done by comparing the number of excitatory postsynaptic potentials (EPSPs) during a 20-s interval that exceeded 5 mV before, during, and after drug application. Evoked potentials were obtained by simultaneous whole cell recording from monosynaptically coupled M/T cells and interneurons. Electrical stimulation of a presynaptic M/T cell evoked an action potential, which was recorded as an excitatory postsynaptic potential in the postsynaptic interneuron. Membrane input resistance was determined in current-clamp mode as well, using a current injection varying from 30–55 pA. To examine membrane currents evoked by glutamate-receptor agonists, whole cell recordings were made from interneurons in discontinuous, single-electrode, voltage-clamp mode at a switch frequency of 8–12 kHz. Membrane currents were filtered at 1–3 kHz and digitized at 5–10 kHz. Calcium current data were gathered in continuous, single-electrode, voltage-clamp mode to help reduce electrical noise. To more easily identify and quantify an effect on calcium channels, 10 mM BaCl2 was substituted for CaCl2 in the experimental drug solutions. Tetrodotoxin (1 µM) was added to block sodium currents, and Cs-based intracellular solutions were used to block potassium currents.

Immunocytochemistry

Our immunocytochemical procedures were modified from previous protocols (Trombley and Westbrook 1990Go). Primary neuronal cultures were rinsed three times for 10 min with phosphate-buffered saline (PBS) and fixed for 30 min in 4% buffered formaldehyde, which was osmotically adjusted to 320 mOsm with sucrose. The cultures were then rinsed three times for 10 min with PBS. To prevent nonspecific antibody binding, a blocking solution containing 10% normal donkey serum (NDS) or normal rabbit serum in PBS was added to each fixed culture for 10 min. The blocking solution was removed by rinsing three times for 10 min with PBS. The primary antibody was diluted in PBS then added to the cultures to incubate for 24 h at room temperature. The next day, the cultures were rinsed three times for 10 min with PBS to remove the primary antibody. The secondary antibody also was diluted in PBS and added to the cultures for 1 h. After incubation, the secondary antibody was removed by washing three times for 10 min with PBS. All PBS was then removed, and coverslips were applied inside the culture dish using Aquamount (Fisher Scientific, Fairlawn, NJ). The primaries used were a mouse anti-tyrosine hydroxylase monoclonal antibody (Chemicon International, Temecula, CA) at a 1:10,000 dilution and a goat anti-D2 receptor polyclonal antibody (Santa Cruz Biotech, Santa Cruz, CA) at a 1:1,000 dilution. The corresponding secondaries were a goat anti-mouse IgG conjugated to Cy3 (Jackson Immunoresearch, West Grove, PA) used at a 1:200 dilution for TH and a rabbit anti-goat IgG conjugated to AlexaFluor 568 (Molecular Probes, Eugene, OR) at a 1:3,000 dilution for D2 receptors. The fluorescent images were acquired on a Leica DM-LFS microscope using OpenLab 3.0 software.

Statistics

All statistics were performed using GraphPad Prism version 3.00 (San Diego, CA). Data were analyzed using a one-way ANOVA with Newman-Keuls multiple comparison post-test. All data are presented as the mean ± SE.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Tyrosine hydroxylase and D2 receptor expression in primary culture in the absence of olfactory sensory neuron innervation

Several studies have shown that innervation by olfactory sensory neurons is necessary to maintain both dopamine content (Kawano and Margolis 1982Go) and TH expression in OB juxtaglomerular cells (Baker et al. 1983Go; Brunjes et al. 1985Go; Cho et al. 1996Go). To determine whether dopamine could be synthesized in our cultures in the absence of olfactory sensory neurons, immunocytochemical techniques were used to examine TH expression. TH was expressed in every culture dish examined (n = 7; Fig. 1A), independent of the age of the animal at dissection (P1–P5) or time in vitro (7–12 days). Approximately 1% of the neurons were immunoreactive for TH. Immunocytochemical controls were prepared by omitting addition of the primary antibody in some cultures and by substituting NDS for primary antibody in others. No significant amount of secondary binding occurred in either situation. These results suggest that dopamine is likely synthesized in primary culture without innervation from the olfactory epithelium.



View larger version (16K):
[in this window]
[in a new window]
 
FIG. 1. A: fluorescent immunocytochemical detection confirmed the presence of tyrosine hydroxylase in cultured neurons. This implies that some neurons in culture can express dopamine without olfactory epithelium innervation. Scale bar =100 µm. B: fluorescent immunocytochemical detection also confirmed the presence of dopamine D2 receptors in cultured mitral/tufted neurons. Scale bar =10 µm.

 

Although it has been suggested that the majority of OB dopamine D2 receptors are expressed in olfactory sensory terminals (Guthrie et al. 1991Go; Koster et al. 1999Go), other studies support the notion that D2 receptors are expressed by OB neurons (Coronas et al. 1997Go; Levey et al. 1993Go; Mansour et al. 1990Go) and are functional (Brunig et al. 1999Go; Coronas et al. 1999Go). To address this issue further, we used immunocytochemical techniques to determine whether D2 receptors are expressed by the cultures we examined electrophysiologically. The majority of OB neurons, including M/T cells (Fig. 1B), were immunoreactive for D2 receptors. Neurons from control cultures, which were exposed to the secondary antibody but not the primary, were not immunoreactive. These results are consistent with our electrophysiological results in which the majority of OB neurons were sensitive to dopamine or the D2 receptor agonist, bromocriptine.

Dopamine inhibits spontaneous excitatory synaptic activity

To determine whether dopamine has any effect on excitatory synaptic transmission between OB neurons, whole cell current-clamp recordings were obtained from interneurons before, during, and after dopamine (30 µM) application (Fig. 2). In 13 of the 14 cells tested, spontaneous excitatory activity in the interneuron was substantially inhibited during dopamine application. Dopamine reduced the number of excitatory synaptic events >5 mV during a 20-s interval to 24.2 ± 7.2% of control. The latency of recovery to baseline activity ranged from 10 s to 3 min. Figure 2 shows an example of the recovery latency. That the recovery was not instantaneous was likely due to the metabotropic nature of dopamine receptors and the duration necessary to inactivate the effects of second messengers.



View larger version (22K):
[in this window]
[in a new window]
 
FIG. 2. Application of 30 µM dopamine to a spontaneously active interneuron resulted in marked inhibition (n = 13 of 14) of action potentials and excitatory postsynaptic potentials. Third and 4th traces show the time course of recovery. Duration of each sweep was 20 s; the intersweep interval was ~5 s.

 

To determine which dopamine receptor subtype was mediating the inhibitory effect of dopamine, spontaneous activity in interneurons was examined in the presence of dopamine receptor subtype-selective agonists. Application of the D2 receptor agonist bromocriptine mesylate (1 µM) dramatically inhibited spontaneous excitatory activity in 9 of 13 neurons (Fig. 3, 2nd trace). Bromocriptine reduced the number of excitatory synaptic events >5 mV in a 20-s interval to 21.8 ± 6.3% of control. Application of 30 µM SKF38393, a D1 receptor agonist, inhibited spontaneous excitatory transmission in 12 of 14 neurons tested (Fig. 3, 4th trace). SKF38393 reduced the number of excitatory synaptic events >5 mV during a 20-s interval to 36.1 ± 8.8% of control. The effects of dopamine, bromocriptine, and SKF38393 on the excitatory synaptic event number were not statistically different from one another (P > 0.05). Like dopamine, both SKF38393 and bromocriptine exerted effects on both individual and compound EPSPs.



View larger version (22K):
[in this window]
[in a new window]
 
FIG. 3. D2 receptor agonist bromocriptine (1 µM) and D1 receptor agonist SKF38393 (30 µM) were sequentially applied to a spontaneously active interneuron. Bromocriptine dramatically inhibited spontaneous excitatory activity in a manner similar to the inhibition observed with dopamine (n = 9 of 13). SKF38393 also mimicked dopamine's inhibitory effect on spontaneous excitatory transmission (n = 12 of 14). Like dopamine, bromocriptine and SKF38393 inhibited both individual and compound excitatory postsynaptic potentials (EPSPs).

 

Dopamine attenuates evoked EPSPs in interneurons

Dopamine could reduce spontaneous excitatory transmission as an indirect consequence of increasing spontaneous inhibitory transmission. That is, increasing inhibition onto excitatory neurons could reduce the probability of glutamate release from excitatory neurons. To eliminate this type of network effect as the basis of dopamine's actions on excitatory synaptic transmission, identified pre- and postsynaptic neurons were isolated by recording from monosynaptically coupled neuron pairs. After both a M/T cell and an interneuron were whole cell patch-clamped, a suprathreshold positive current pulse was injected to evoke an action potential in the M/T cell. The amplitude and the kinetics of the subsequent EPSP evoked in the interneuron were then analyzed.

The group of traces in Fig. 4 are representative data, consisting of reliable, time-locked EPSPs from an interneuron following an evoked action potential in a presynaptic M/T cell. In the presence of 30 µM dopamine, the peak amplitude of the EPSP decreased to 68 ± 7% of the control amplitude (n = 6, P < 0.001). Neither the 10–90% rise time of the EPSP nor the presynaptic action potential shape or amplitude were modified by dopamine (P > 0.05). Following dopamine removal, the amplitude of the EPSP recovered to control values (Fig. 4A). As shown in Fig. 4B, application of 1 µM bromocriptine, a D2 receptor agonist, mimicked the dopamine-mediated attenuation of EPSP amplitude (62 ± 4% of control, n = 5, P < 0.02). As with dopamine, the 10–90% rise time of the EPSP was not affected (P > 0.05). However, the neurons did not recover well from the effects of bromocriptine after washout, perhaps due to the very high binding affinity of bromocriptine for the D2 receptor (Coronas et al. 1999Go). In contrast to the effects of D2 receptor activation, D1 receptor activation with the selective D1 receptor agonist SKF38393 (30 µM) did not significantly affect monosynaptic transmission (n = 8, P = 0.67), as shown in Fig. 4C. SKF38393 also did not alter the 10–90% rise time of the EPSP (P > 0.05).



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 4. EPSPs were evoked in interneurons that were monosynaptically paired with mitral/tufted (M/T) cells. The bottom of the figure shows a representative trace of the action potential evoked in the presynaptic M/T cell that evoked the EPSP in the interneuron. A: application of 30 µM dopamine decreased the peak amplitude of the evoked EPSP to 68 ± 7% of the control amplitude (n = 6, P < 0.001). B: bromocriptine (1 µM) mimicked the effects of dopamine by attenuating evoked EPSPs to 62 ± 4% of the control amplitude (n = 5, P < 0.02). C: SKF38393 (30 µM) had no significant effect on monosynaptic transmission (n = 8, P = 0.67). Summary histograms are shown on the right. Significant differences (P ≤ 0.05) between control and drug treatment are indicated by an asterisk.

 

Dopamine exerts no direct effect on the postsynaptic interneuron

We also wanted to determine whether the effects of dopamine on excitatory transmission were presynaptic, postsynaptic, or both. First, we examined the effects of dopamine on membrane resistance in the interneuron, since a decrease in postsynaptic membrane resistance would reduce the EPSP amplitude. Hyperpolarizing current injections (250 ms, 30–55 pA) were made in interneurons in current-clamp mode from a membrane potential of –60 mV. Flow-pipe application of 30 µM dopamine had no effect on the amplitude or kinetics of the resulting voltage deflection (n = 4, Fig. 5A). This result suggests that dopamine neither directly opens nor closes ion channels in the postsynaptic cell membrane sufficiently to cause a measurable change in resistance.



View larger version (15K):
[in this window]
[in a new window]
 
FIG. 5. Dopamine has no detectable direct postsynaptic effects. A: hyperpolarizing current was injected into an interneuron, and voltage deflection was recorded as a measure of membrane resistance. The 3 overlaid traces show that before, during, and after the application of 30 µM dopamine, there was no change in membrane resistance. B: to determine whether dopamine was acting directly on glutamate-activated ion channels in interneurons, 30 µM dopamine was coapplied with 500 µM glutamate during an evoked glutamate-mediated current. Dopamine did not alter the current amplitude (n = 8). C: comparison of the current evoked by glutamate alone to the current evoked by the combination of glutamate and dopamine. Kinetics and amplitude of glutamate-evoked currents were not altered by dopamine (n = 6).

 

Dopamine has no direct effects on glutamate receptors

A second hypothesis is that dopamine reduces EPSP amplitude via inhibition of postsynaptic glutamate receptors. To test this hypothesis, interneurons were whole cell voltage-clamped at –65 mV, and a glutamate receptor-mediated current was evoked by flow-pipe application of 500 µM glutamate, a concentration that activates all subtypes of ionotropic glutamate receptors. Dopamine (30 µM) was then coapplied during the glutamate-evoked current. Dopamine had no effect on either the kinetics or amplitude of the glutamate-mediated current (n = 8, Fig. 5B). Potential effects of dopamine on glutamate receptors were further examined by comparing currents evoked by glutamate alone with currents evoked by the coapplication of glutamate and dopamine (Fig. 5C). (These traces are in contrast to the trace in 5B, in which dopamine was coapplied during the middle of a glutamate-evoked current). Under these conditions too, dopamine did not alter the glutamate-evoked current (Fig. 5C, n = 6).

The possibility that prolonged exposure is required for dopamine to exert its effects was also tested. The initial current evoked by 500 µM glutamate served as a control. The neurons were incubated in 100 µM dopamine for 15–20 min, and glutamate was reapplied. Preincubation with dopamine did not affect the amplitude of the current evoked by glutamate (data not shown). This lack of evidence for postsynaptic modulation of glutamate-mediated excitation by dopamine suggests that the presynaptic M/T cell is the likely target of dopamine's action.

Dopamine inhibits calcium channel currents in M/T cells

Because calcium channel modulation is a common mechanism of action for presynaptic inhibition, the effect of dopamine on calcium channel currents in M/T cells was examined. M/T cells were voltage clamped at –60 mV and stepped to 0 mV for 50 ms. For ease of analysis, 10 mM Ba was substituted for Ca to enhance the amplitude of the current. Sodium currents were blocked with 1 µM TTX, and potassium currents were blocked with intracellular Cs. As shown in Fig. 6A, calcium channel currents were diminished to 30 ± 7% of control amplitudes (n = 8 of 11, P < 0.001) in the presence of 30 µM dopamine. Due to a combination of the rundown of calcium currents over time (which normally occurs with whole cell recording) and possible lingering dopaminergic effects, the currents in the cells tested only recovered to 67% of their original amplitudes. Application of 1 µM bromocriptine also attenuated calcium currents in M/T cells (Fig. 6B). Bromocriptine diminished calcium currents to 66 ± 5% of the original amplitude, with subsequent recovery to 83% of the original current amplitude (n = 8 of 12, P < 0.001). Although dopamine and bromocriptine had similar effects on evoked EPSPs, dopamine had a greater effect on calcium channel currents. A potential explanation for this discrepancy is that dopamine activates additional dopamine receptors that also attenuate calcium channel currents. In contrast to dopamine and bromocriptine, the reduction in calcium channel currents in response to application of 30 µM SKF38393 was no greater than that expected from normal current rundown (n = 7; Fig. 6C).



View larger version (38K):
[in this window]
[in a new window]
 
FIG. 6. Dopamine diminishes voltage-gated calcium channel currents in presynaptic M/T cells. A: Dopamine (30 µM) attenuated the evoked calcium channel current to 30 ± 7% of control amplitudes (n = 8 of 11, P < 0.001). The calcium current recovered to only 67% of its original amplitude, likely due to either the lingering dopaminergic response, the expected rundown of the current, or both. B: via D2 receptor activation, application of bromocriptine (1 µM) also attenuated calcium channel currents. Bromocriptine reduced currents to 66 ± 5% of control amplitudes, with recovery to 83% of the original current amplitude (n = 8 of 12, P < 0.001). C: application of 30 µM SKF38393 did not reduce calcium channel currents beyond what could be attributed to current rundown (n = 7). D: blockade of L-type calcium channels with 10–100 µM nifedipine reduced the calcium channel currents to 64 ± 5% of control (n = 9, P < 0.01). Subsequent dopamine (30 µM) application in the presence of nifedipine further attenuated the remaining calcium channel current by 29 ± 7% (n = 9, P < 0.001). Summary histograms are shown on the right. Significant differences (P < 0.05) between control and drug treatment are indicated by an asterisk. Significant differences (P < 0.05) between drug treatment and wash are indicated by an x.

 

To further identify the type of calcium channels affected by dopamine, 30 µM dopamine was applied after the L-type channels had been blocked by nifedipine (10–100 µM). Nifedipine alone reduced the calcium channel current to 64 ± 5% of control (n = 9, P < 0.01). Application of dopamine blocked the nifedipine-resistant calcium channel currents by 29 ± 7% (Fig. 6D, n = 9, P < 0.001). These results suggest that dopamine can inhibit the dihydropyridine-resistant high-voltage calcium channels (N- and P/Q-type) previously implicated in transmitter release in the OB (Isaacson 2001Go; Isaacson and Strowbridge 1998Go). The effects of nifedipine at 10 µM were near saturating and not significantly different those at 100 µM (data not shown). The degree of calcium channel current block at either 10 or 100 µM nifedipine was similar to the 40% block with 10 µM nifedipine previously observed in these neurons (Trombley 1992Go).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
It has been recently reported that dopamine can modulate glutamate release from olfactory receptor neuron nerve terminals via a presynaptic D2 receptor-mediated mechanism (Berkowicz and Trombley 2000Go; Ennis et al. 2001Go; Hsia et al. 1999Go). This study suggests that activation of presynaptic D2 receptors on M/T cells can also attenuate glutamatergic transmission between OB neurons and that the effect may be mediated by inhibition of calcium channels.

Synaptic organization and dopamine neurons in the OB

The axons of the olfactory sensory neurons enter the OB and innervate periglomerular (PG) neurons, superficial tufted cells, and the primary dendrites of mitral cells within glomeruli. Each glomerulus is thought to operate as a functional unit, and each responds best to a specific group of odors (Mombaerts 1999Go). The GABAergic PG neurons that circumscribe the glomeruli mediate feedback inhibition within glomeruli and lateral (feedforward) inhibition between glomeruli (Shepherd 1972Go). A large subset of PG cells is also dopaminergic (Gall et al. 1987Go; Kosaka et al. 1985Go), as is a subpopulation of superficial tufted cells (Halasz et al. 1981Go). The latter neurons make reciprocal dendrodendritic synapses with PG cells and often project their axon collaterals to synapse on PG and short axon cell bodies (Pinching and Powell 1971Go). Their axons and axon collaterals may not project outside the bulb, and the function of these neurons is not yet understood.

Although it has been reported that olfactory nerve transection reduces TH and dopamine expression in the OB (Brunjes et al. 1985Go), the present study provides immunocytochemical evidence that there is significant expression of TH (and perhaps, dopaminergic transmission) in cultured neurons in the absence of olfactory sensory neuron input. The proportion of TH-immunoreactive neurons in our cultures is consistent with recent findings in cultured neurons (Cigola et al. 1998Go; Puche et al. 1999Go) and the intact bulb (McLean and Shipley 1998). Cigola and colleagues reported that a 48-h treatment with high external potassium concentrations, used to maintain membrane depolarization, increased baseline TH expression in mouse OB cultures 2.4-fold. Application of an L-type calcium channel antagonist blocked this increase in expression (Cigola et al. 1998Go). Puche and colleagues reported that co-culturing rat OB cells with olfactory epithelium also caused a 2.4-fold increase in TH expression. Interestingly, they found that application of an N-methyl-D-aspartate (NMDA) receptor antagonist could block this effect. These data suggest that calcium influx is an important modulator of TH expression and that the route of calcium entry may be either through NMDA receptors or voltage-gated calcium channels.

Our use of astrocyte feeder layers promotes high neuronal survival and rapid formation of synaptic contacts. Given this, our data may suggest that ongoing spontaneous synaptic activation of NMDA receptors and/or depolarization sufficient to activate voltage-gated calcium channels are adequate to maintain levels of TH expression in culture similar to those observed in the intact bulb (McLean and Shipley 1998). Alternatively, some expression of TH may be independent of these mechanisms. Differentiation between these hypotheses awaits further experimentation.

Dopamine modulates neurotransmission

Previous reports have shown that dopamine can modulate neurotransmission in the OB. In the turtle OB, exogenous dopamine application both delayed the onset and decreased the amplitude of field potentials recorded from mitral cells (Nowycky et al. 1983Go). More recently, in the rat and turtle OB, olfactory sensory neuron activation of mitral cells was reduced in the presence of dopamine or D2 receptor agonists (Berkowicz and Trombley 2000Go; Ennis et al. 2001Go; Hsia et al. 1999Go). Ennis et al. (2001Go) also reported that dopamine inhibits olfactory sensory neuron activation of M/T cells in both rat and mouse and further demonstrated that dopamine inhibits olfactory sensory neuron activation of juxtaglomerular cells. Significantly, these effects were eliminated in D2 receptor knockout mice.

The present results are consistent with these previous reports. They also provide additional understanding of the role of dopamine by demonstrating that dopamine can modulate excitatory transmission between OB M/T cells and interneurons. Our results, as well as the results of Brunig et al. (1999Go) described in the next paragraph, support the notion of functional D2 receptors on M/T cells. However, in contrast to our results, Ennis et al. (2001Go) reported that dopamine had no effect on mitral cell-evoked excitatory postsynaptic currents (EPSCs) in juxtaglomerular cells. Although the reason for this discrepancy is unclear, there are at least several possible explanations. The experiments by Ennis and colleagues were conducted in mice, whereas ours were in rats; there may be species differences that explain the different findings. In addition, their protocol (stimulation of the mitral cell layer or lateral olfactory tract) generated long-lasting bursts of EPSCs. Under these conditions, initial monosynaptic events are difficult to resolve. In some of our experiments, we used synaptically coupled pairs of neurons; this allowed us to focus the effects of dopamine on the initial monosynaptic component of transmission between M/T cells and interneurons, while also eliminating polysynaptic or network effects. It is possible that these initial monosynaptic events are more sensitive to the effects of dopamine than are the mechanisms that underlie bursting behavior. Another possible explanation for these disparate findings is that mitral and tufted cells may differ in their sensitivity to dopamine. It is possible that many of our experiments included tufted cell-to-interneuron transmission. In contrast, the experiments by Ennis and colleagues may have included only mitral cell transmission, since five of the six cells examined involved direct stimulation of the mitral cell layer.

Collectively, these results are consistent with observations in other brain regions in the rat, including the parabrachial region (Chen et al. 1999Go), nucleus accumbens (Kalivas and Duffy 1997Go), and ventral tegmental area (Koga and Momiyama 2000Go), where dopamine also decreases glutamatergic neurotransmission. However, the effects of dopamine on neurotransmission are not limited to excitatory transmission. For example, GABAergic inputs to the rat striatum are also sensitive to dopamine receptor-mediated inhibition (Delgado et al. 2000Go). Dopamine also modulates inhibitory transmission of OB neurons in culture. Brunig et al. (1999Go) reported that D1 receptor activation attenuates GABA-gated chloride currents in cultured interneurons and that stimulation of D2 receptors on cultured M/T cells potentiates GABA-gated chloride currents. These findings by Brunig and colleagues may explain why the D1 receptor agonist SKF38393 appeared to affect spontaneous activity in our experiments while not affecting other aspects of excitatory neurotransmission (e.g., evoked monosynaptic potentials, voltage-gated calcium currents, membrane resistance). That is, a SKF38393-mediated reduction in inhibition of GABAergic interneurons, which could potentiate inhibition of M/T cells, could secondarily reduce spontaneous excitatory transmission.

Dopamine's effects may be mediated via inhibition of calcium channel currents

In the present experiments, as in most of the cited examples, the effects of dopamine appear to be presynaptic. This interpretation is based on our finding that dopamine did not directly affect postsynaptic membrane resistance nor directly inhibit postsynaptic glutamate-mediated currents. It is also supported by previous OB studies demonstrating that dopamine has no effect on M/T cell NMDA, AMPA, or kainate receptors (Berkowicz and Trombley 2000Go), juxtaglomerular cell input resistance, or the amplitude of miniature excitatory postsynaptic currents (Ennis et al. 2001Go; Hsia et al. 1999Go). Furthermore, the possibility that postsynaptic effects on network behavior were indirectly mediating dopamine's effects on excitatory transmission (as might occur with recording of spontaneous activity) was eliminated by recording from monosynaptically coupled pairs of identified M/T cells and interneurons.

It has been demonstrated in the turtle that dopamine reduces calcium influx in olfactory sensory neuron terminals (Wachowiak and Cohen 1999Go) and that presynaptic D2 receptor activation inhibits glutamate release from these terminals (Berkowicz and Trombley 2000Go). The fact that dopamine, or D2 receptor agonists, can reduce calcium channel currents evoked from presynaptic M/T cells lends further support to the notion that dopamine reduces excitatory transmission via reductions in glutamate release. Dopamine may have had a greater effect on calcium channel currents than bromocriptine because dopamine activates all dopamine receptors (more than 1 of which may affect calcium channels), whereas bromocriptine is selective for D2 receptors. That dopamine and bromocriptine had similar effects on monosynaptic transmission suggests that dopamine's D2 effects on calcium channels is all that is necessary to account for dopamine's effects on EPSPs. Our results on the effects of dopamine and D2 receptor agonists on calcium currents and glutamate release are consistent with recent results from experiments on ventral tegmental neurons (Koga and Momiyama 2000Go).

This is not the first examination of calcium channel currents in cultured OB neurons. From a holding potential of –60 mV, we previously observed calcium currents in cultured M/T cells that activated near –40 mV, peaked at 0 mV, and reversed near +55 (Trombley 1992Go; Trombley and Westbrook 1992Go). Transient or T-type currents were small and rarely observed, even from a holding potential of –100 mV where most T-type channels would be available for activation (Trombley 1992Go; Trombley and Westbrook 1992Go).

Dopamine receptors

The recently cloned dopamine receptors are typically grouped into either the D1 or D2 subfamily according to sequence homology and pharmacological attributes (Neve and Neve 1997Go; Sidhu and Niznik 2000Go). These receptors have a distinct laminar and cellular distribution throughout the OB. In the rat, D1 receptors are found in the glomerular, external plexiform, mitral cell, internal plexiform, and granule cell layers, whereas D2 receptors are located in the olfactory nerve, glomerular, and external plexiform layers (Coronas et al. 1997Go; Levey et al. 1993Go; Mansour et al. 1990Go; Nickell et al. 1991Go).

Although there is some controversy, several studies support the notion that M/T cells express D2 receptors. Although not specifically addressed in the text, autoradiographic in situ hybridization data presented by Mansour et al. (1990Go) suggest that D2 receptor mRNA is expressed in the mitral cell layer. Levey et al. (1993Go) reported D2 receptor immunoreactivity in the external plexiform layer as well as the glomerular and olfactory nerve layers. In a functional study, Brunig et al. (1999Go) demonstrated a D2 receptor-mediated action on GABAA receptor-mediated currents in M/T cells. In the present study, we provide immunocytochemical evidence of D2 receptors on M/T cells. Furthermore, our electrophysiological data showing that dopamine and the D2 receptor agonist bromocriptine modulate calcium channels and excitatory transmission between M/T cells and interneurons indicate that these receptors are functional.

Dopamine receptors are metabotropic. Therefore each receptor subtype may interact with G-proteins specific to a certain cell type or location (Sidhu and Niznik 2000Go), resulting in cell type-specific effects. Brunig et al. (1999Go) have reported that dopamine modulates GABAA receptors in rat OB in a cell-specific manner that involves differential effects at D1 and D2 receptors. Dopamine reduced currents through GABA-gated Cl-channels in interneurons via activation of D1 receptors and subsequent phosphorylation of GABAA receptors by protein kinase A. In contrast, dopamine enhanced GABA-mediated responses in M/T cells via activation of D2 receptors and phosphorylation of GABAA receptors by protein kinase C.

The two receptor subtypes also tend to have a specific synaptic deposition (Brunig et al. 1999Go; Nickell et al. 1991Go), which may allow dopamine to differentially modulate synaptic circuits. Results from the OB and other brain regions indicate that D2 receptors tend to play a presynaptic role and D1 receptors, a postsynaptic role, in neurotransmission (Hsu et al. 1995Go). Our results are consistent with the general notion that D2 receptor activation can reduce transmitter release. In contrast to the effects of the D1 selective agonist SKF38393, the D2 selective agonist bromocriptine mimicked dopamine's inhibition of calcium channel currents and evoked EPSPs.

Significance to olfactory function

Olfactory experience has a significant effect on the concentration of both TH and dopamine within the OB (Baker et al. 1983Go). Olfactory deprivation, from either unilateral olfactory nerve transection or unilateral naris occlusion, reduces OB dopamine content in the ispsilateral bulb by as much as 75% (Baker et al. 1983Go) and enhances bulb responsiveness to odors, as measured by single-unit recordings and 2-deoxyglucose autoradiography (Guthrie et al. 1990Go; Wilson and Sullivan 1995Go). This enhanced responsiveness, as well as a decrease in odor discrimination, is mimicked by application of the D2 receptor antagonist, spiperone (Wilson and Sullivan 1995Go). Other behavioral experiments have shown that activation of D1 or D2 receptors can increase or decrease the threshold for odor detection, respectively (Doty and Risser 1989Go; Doty et al. 1998Go). These results suggest that dopamine may contribute to both odor detection sensitivity and discrimination. Previous electrophysiological studies, along with the present study, may provide synaptic bases for these observations; these studies demonstrate that activation of presynaptic D2 receptors can reduce both olfactory sensory neuron activation of M/T cells and juxtaglomerular cells (Berkowicz and Trombley 2000Go; Ennis et al. 2001Go; Hsia et al. 1999Go) as well as the excitation of inhibitory interneurons by M/T cells. The schematic in Fig. 7 depicts where dopamine may attenuate glutamatergic transmission in the OB. However, a complete understanding of how dopamine may influence the behavior of synaptic circuits important to odor information processing requires further knowledge of what patterns of activity evoke dopamine release (e.g., olfactory sensory neuron and/or M/T cell stimulation of dopaminergic neurons) and whether the conditions of dopamine release can differentially affect circuits (e.g., synaptic transmission from olfactory sensory neuron to M/T cell, olfactory sensory neuron to juxtaglomerular cell, or M/T to interneuron).



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 7. Diagram of olfactory bulb circuitry and loci of dopamine action. Dopamine released by periglomerular (PG) and/or tufted (T) cells inhibits synaptic transmission between olfactory sensory neurons (OSNs) and olfactory bulb neurons (M/T cells and PG cells) via activation of presynaptic D2 receptors on OSN terminals. These results suggest that dopamine also can act presynaptically to inhibit synaptic transmission between mitral (M) and/or T cells and interneurons. Circled minus signs depict sites of dopamine's inhibitory action. Solid arrows indicate inhibitory transmission, and open arrows indicate excitatory transmission. Olfactory sensory neuron, OSN; glomerulus, GL; periglomerular cells, PG; tufted cells, T; mitral cells, M; granule cells, GR.

 


    ACKNOWLEDGMENTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
The authors thank Dr. Michelle S. Horning for assistance with tissue culture and electrophysiological techniques and the laboratory of Dr. Marc Freeman for generously supplying antibodies and agonists.

This work has been supported in part by the National Institute for Deafness and Other Communication Disorders. N. G. Davila was supported by a National Institutes of Health Joint Neuroscience Predoctoral Training Grant and a National Research Service Award DC-05354-01 from the National Institute for Deafness and Other Communication Disorders.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests: N. G. Davila, Dept. of Biological Science, Program in Neuroscience, Florida State Univ., Tallahassee, FL 32306-4340 (E-mail: davila{at}neuro.fsu.edu).


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 ACKNOWLEDGMENTS
 REFERENCES
 
Baker H, Kawano T, Margolis FL, and Joh TH. Transneuronal regulation of tyrosine hydroxylase expression in olfactory bulb of mouse and rat. J Neurosci 3: 69–78, 1983.[Abstract]

Berkowicz DA and Trombley PQ. Dopaminergic modulation at the olfactory nerve synapse. Brain Res 855: 90–99, 2000.[ISI][Medline]

Brunig I, Sommer M, Hatt H, and Bormann J. Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci USA 96: 2456–2460, 1999.[Abstract/Free Full Text]

Brunjes PC, Smith-Crafts LK, and McCarty R. Unilateral odor deprivation: effects on the development of olfactory bulb catecholamines and behavior. Brain Res 354: 1–6, 1985.[Medline]

Chen X, Kombian SB, Zidichouski JA, and Pittman QJ. Dopamine depresses glutamatergic synaptic transmission in the rat parabrachial nucleus in vitro. Neuroscience 90: 457–468, 1999.[ISI][Medline]

Cho JY, Min N, Franzen L, and Baker H. Rapid down-regulation of tyrosine hydroxylase expression in the olfactory bulb of naris-occluded adult rats. J Comp Neurol 369: 264–276, 1996.[ISI][Medline]

Cigola E, Volpe BT, Lee JW, Franzen L, and Baker H. Tyrosine hydroxylase expression in primary cultures of olfactory bulb: role of L-type calcium channels. J Neurosci 18: 7638–7649, 1998.[Abstract/Free Full Text]

Coronas V, Krantic S, Jourdan F, and Moyse E. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach. Neuroscience 90: 69–78, 1999.[ISI][Medline]

Coronas V, Srivastava LK, Liang JJ, Jourdan F, and Moyse E. Identification and localization of dopamine receptor subtypes in rat olfactory mucosa and bulb: a combined in situ hybridization and ligand binding radioautographic approach. J Chem Neuroanat 12: 243–257, 1997.[ISI][Medline]

Delgado A, Sierra A, Querejeta E, Valdiosera RF, and Aceves J. Inhibitory control of the GABAergic transmission in the rat neostriatum by D2 dopamine receptors. Neuroscience 95: 1043–1048, 2000.[ISI][Medline]

Doty RL, Li C, Bagla R, Huang W, Pfeiffer C, Brosvic GM, and Risser JM. SKF 38393 enhances odor detection performance. Psychopharmacology 136: 75–82, 1998.[Medline]

Doty RL and Risser JM. Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration. Psychopharmacology 98: 310–315, 1989.[Medline]

Ennis M, Zhou FM, Ciombor KJ, Aroniadou-Anderjaska V, Hayar A, Borrelli E, Zimmer LA, Margolis F, and Shipley MT. Dopamine d2 receptor-mediated presynaptic inhibition of olfactory nerve terminals. J Neurophysiol 86: 2986–2997, 2001.[Abstract/Free Full Text]

Gall CM, Hendry SH, Seroogy KB, Jones EG, and Haycock JW. Evidence for coexistence of GABA and dopamine in neurons of the rat olfactory bulb. J Comp Neurol 266: 307–318, 1987.[ISI][Medline]

Guthrie KM, Pullara JM, Marshall JF, and Leon M. Olfactory deprivation increases dopamine D2 receptor density in the rat olfactory bulb. Synapse 8: 61–70, 1991.[ISI][Medline]

Guthrie KM, Wilson DA, and Leon M. Early unilateral deprivation modifies olfactory bulb function. J Neurosci 10: 3402–3412, 1990.[Abstract]

Halasz N, Johansson O, Hokfelt T, Ljungdahl A, and Goldstein M. Immunohistochemical identification of two types of dopamine neuron in the rat olfactory bulb as seen by serial sectioning. J Neurocytol 10: 251–259, 1981.[ISI][Medline]

Hsia AY, Vincent JD, and Lledo PM. Dopamine depresses synaptic inputs into the olfactory bulb. J Neurophysiol 82: 1082–1085, 1999.[Abstract/Free Full Text]

Hsu KS, Huang CC, Yang CH, and Gean PW. Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum. Brain Res 690: 264–268, 1995.[ISI][Medline]

Isaacson JS. Mechanisms governing dendritic gamma-aminobutyric acid (GABA) release in the rat olfactory bulb. Proc Natl Acad Sci USA 98: 337–342, 2001.[Abstract/Free Full Text]

Isaacson JS and Strowbridge BW. Olfactory reciprocal synapses: dendritic signaling in the CNS. Neuron 20: 749–761, 1998.[ISI][Medline]

Kalivas PW and Duffy P. Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761: 173–177, 1997.[ISI][Medline]

Kawano T and Margolis FL. Transsynaptic regulation of olfactory bulb catecholamines in mice and rats. J Neurochem 39: 342–348, 1982.[ISI][Medline]

Koga E and Momiyama T. Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J Physiol 523: 163–173, 2000.[Abstract/Free Full Text]

Kosaka T, Hataguchi Y, Hama K, Nagatsu I, and Wu JY. Coexistence of immunoreactivities for glutamate decarboxylase and tyrosine hydroxylase in some neurons in the periglomerular region of the rat main olfactory bulb: possible coexistence of gamma-aminobutyric acid (GABA) and dopamine. Brain Res 343: 166–171, 1985.[ISI][Medline]

Koster NL, Norman AB, Richtand NM, Nickell WT, Puche AC, Pixley SK, and Shipley MT. Olfactory receptor neurons express D2 dopamine receptors. J Comp Neurol 411: 666–673, 1999.[ISI][Medline]

Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, and Ciliax BJ. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90: 8861–8865, 1993.[Abstract/Free Full Text]

Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, and Watson SJ. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J Neurosci 10: 2587–2600, 1990.[Abstract]

McLean JH and Shipley MT. Postmitotic, postmigrational expression of tyrosine hydroxylase in olfactory bulb dopaminergic neurons, J Neurosci 8: 3658–69, 1988.[Abstract]

Mombaerts P. Molecular biology of odorant receptors in vertebrates. Annu Rev Neurosci 22: 487–509, 1999.[ISI][Medline]

Neve KA and Neve RL. The Dopamine Receptors. Totowa: Humana Press, 1997.

Nickell WT, Norman AB, Wyatt LM, and Shipley MT. Olfactory bulb DA receptors may be located on terminals of the olfactory nerve. Neuroreport 2: 9–12, 1991.[ISI][Medline]

Nowycky MC, Halasz N, and Shepherd GM. Evoked field potential analysis of dopaminergic mechanisms in the isolated turtle olfactory bulb. Neuroscience 8: 717–722, 1983.[ISI][Medline]

Pinching AJ and Powell TP. The neuropil of the periglomerular region of the olfactory bulb. J Cell Sci 9: 379–409, 1971.[Abstract/Free Full Text]

Puche AC and Shipley MT. Odor-induced, activity-dependent transneuronal gene induction in vitro: mediation by NMDA receptors. J Neurosci 19: 1359–1370, 1999.[Abstract/Free Full Text]

Shepherd GM. Synaptic organization of the mammalian olfactory bulb. Physiol Rev 52: 864–917, 1972.[Free Full Text]

Sidhu A and Niznik HB. Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int J Dev Neurosci 18: 669–677, 2000.[ISI][Medline]

Trombley PQ. Norepinephrine inhibits calcium currents and EPSPs via a G-protein coupled mechanism in olfactory bulb neurons. J Neurosci 12: 3992–3998, 1992.[Abstract]

Trombley PQ and Blakemore LJ. Mammalian olfactory bulb neurons. In: The Neuron in Tissue Culture, edited by Haynes LW. West Sussex, UK: Wiley, 1999, p. 585–592.

Trombley PQ and Westbrook GL. Excitatory synaptic transmission in cultures of rat olfactory bulb. J Neurophysiol 64: 598–606, 1990.[Abstract/Free Full Text]

Trombley PQ and Westbrook GL. L-AP4 inhibits calcium currents and synaptic transmission by a G-protein coupled glutamate receptor. J Neurosci 12: 2043–2050, 1992.[Abstract]

Wachowiak M and Cohen LB. Presynaptic inhibition of primary olfactory afferents mediated by different mechanisms in lobster and turtle. J Neurosci 19: 8808–8817, 1999.[Abstract/Free Full Text]

Wilson DA and Sullivan RM. The D2 antagonist spiperone mimics the effects of olfactory deprivation on mitral/tufted cell odor response patterns. J Neurosci 15: 5574–5581, 1995.[Abstract]




This article has been cited by other articles:


Home page
Chem SensesHome page
A. Pignatelli and O. Belluzzi
Cholinergic Modulation of Dopaminergic Neurons in the Mouse Olfactory Bulb
Chem Senses, April 1, 2008; 33(4): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Beshel, N. Kopell, and L. M. Kay
Olfactory Bulb Gamma Oscillations Are Enhanced with Task Demands
J. Neurosci., August 1, 2007; 27(31): 8358 - 8365.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F.-A. Weltzien, C. Pasqualini, M.-E. Sebert, B. Vidal, N. Le Belle, O. Kah, P. Vernier, and S. Dufour
Androgen-Dependent Stimulation of Brain Dopaminergic Systems in the Female European Eel (Anguilla anguilla)
Endocrinology, June 1, 2006; 147(6): 2964 - 2973.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Puopolo, B. P. Bean, and E. Raviola
Spontaneous Activity of Isolated Dopaminergic Periglomerular Cells of the Main Olfactory Bulb
J Neurophysiol, November 1, 2005; 94(5): 3618 - 3627.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Pignatelli, K. Kobayashi, H. Okano, and O. Belluzzi
Functional properties of dopaminergic neurones in the mouse olfactory bulb
J. Physiol., April 15, 2005; 564(2): 501 - 514.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page